fap 2286 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
fap 2286
Fap 2286, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fap+2286/FAP-2286/pm41511675-42-0-1
Average 94 stars, based on 10 article reviews
Fap 2286, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fap+2286/FAP-2286/pm41511675-42-0-1
Average 94 stars, based on 10 article reviews
fap 2286 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Biomarker Discovery:Article Title: [68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma Article Snippet: .. Article Title: [ 68 Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [ 18 F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma Article Snippet: .. Control:Article Title: [68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma Article Snippet: .. Article Title: [ 68 Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [ 18 F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma Article Snippet: .. Radioactivity:Article Title: Illuminating radionuclide therapy response: Monitoring cancer cell and CAF survival in a direct 2D co-culture model Article Snippet: Background Targeted radionuclide therapy (TRT) directed at fibroblast activation protein (FAP), highly expressed on cancer-associated fibroblasts (CAFs), is a promising approach for treating stroma-rich tumors such as pancreatic ductal adenocarcinoma (PDAC) and breast cancer (BC).. To better assess the efficacy of FAPTRT and to get more insight into the potential of crossfire effects from target expressing CAFs to neighboring cancer cells, more representative preclinical models are needed.. Therefore, we established a direct 2D co-culture model consisting of both CAFs and cancer cells. Activity Assay:Article Title: Illuminating radionuclide therapy response: Monitoring cancer cell and CAF survival in a direct 2D co-culture model Article Snippet: Background Targeted radionuclide therapy (TRT) directed at fibroblast activation protein (FAP), highly expressed on cancer-associated fibroblasts (CAFs), is a promising approach for treating stroma-rich tumors such as pancreatic ductal adenocarcinoma (PDAC) and breast cancer (BC).. To better assess the efficacy of FAPTRT and to get more insight into the potential of crossfire effects from target expressing CAFs to neighboring cancer cells, more representative preclinical models are needed.. Therefore, we established a direct 2D co-culture model consisting of both CAFs and cancer cells. Labeling:Article Title: Head-to-head comparison of [ 177 Lu]Lu-FAP-2286 and [ 161 Tb]Tb-FAP-2286 efficacy in a PDAC mouse model Article Snippet: .. Article Title: Head-to-head comparison of [ 177 Lu]Lu-FAP-2286 and [ 161 Tb]Tb-FAP-2286 efficacy in a PDAC mouse model. Article Snippet: .. |
![Chemical structures of clinically evaluated tumour-direct <t>FAP,</t> PSMA, and SSTR targeting radiopharmaceuticals. Representative clinically evaluated tumour-directed FAP-, PSMA- and SSTR-targeting radiopharmaceuticals. PSMA-targeting radiopharmaceuticals with a glutamate-urea-lysine structural motif, including PSMA-11, PSMA-1007, PSMA-617, and rhPSMA-7.3, have been approved. PSMA-targeting ligands that enable simultaneous diagnosis and therapy, including PSMA-I&T and rhPSMA, are of high value. SSTR-targeting radiopharmaceuticals play essential roles in the radiotheranostics of NETs. The antagonists, including LM3 and JR11, which have greater safety and affinity, are promising in SSTR-targeting imaging agents. FAP-targeting radiotracers may prove advantageous over [ 18 F]FDG in the localization and visualization of solid tumours, such as FAPI-04, FAPI-46, and FAPI-74. <t>Additionally,</t> <t>FAP-2286</t> has been shown to facilitate radiotheranostics. Grey circles: natural amino acids; blue circles: unnatural amino acids; highlighting in red: labelling with fluorine-18; highlighting in purple: chelators for metal radionuclide labelling](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7352/pmc11697352/pmc11697352__41392_2024_2041_Fig5_HTML.jpg)